chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: minor seizure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 17-year-old male patient received BNT162b2 (BNT162B2), on 03Jun2021 as dose 1, single (Lot number: EW0191) at the age of 16 years intramuscular, in Left upper Arm for covid-19 immunisation. The patient's relevant medical history included: "ADHD", start date: 12Mar2013 (ongoing), notes: (Combined type); "Tic disorder", start date: 27Mar2013 (ongoing); "Obsessive behaviors", start date: 12Jun2013 (ongoing); "Astigmatism of both eyes", start date: 29Aug2013 (ongoing); "Congenital nystagmus", start date: 29Aug2013 (ongoing); "Complex partial seizures", start date: 13Feb2014 (ongoing), notes: CMS/HCC; "Retinopathy of prematurity", start date: 20Aug2014 (ongoing); "Autism spectrum disorder", start date: 14Mar2017 (ongoing); "Chronic idiopathic constipation", start date: 14Mar2017 (ongoing); "History of prematurity", start date: 14Mar2017 (ongoing); "Language impairment", start date: 31Oct2017 (ongoing); "Allergic rhinitis" (ongoing); "Autism", start date: 12Mar2013 (ongoing); "Congenital nystagmus", start date: 30Jan2018 (ongoing); "Seizures", start date: 2012, stop date: Jul2019, notes: First seizure was in 2012 until Jul2019; "Seizures" (ongoing), notes: Unknown-present. The patient's concomitant medications were not reported. Past drug history included: Keppra, start date: 2012, stop date: Mar2019. The following information was reported: SEIZURE (medically significant) with onset 10Jun2021, outcome "unknown", described as "minor seizure".  Clinical course: The patient received second dose on 24Jun2021, Batch/Lot No: FA6780 intramuscular, in Left upper Arm and third dose on 13Jul2022, Batch/Lot No: FP7139, in Left upper Arm. Relevant tests and specific Relevant tests was none. withheld first seizure was in 2012. From 2012 until Jul2019, he had 50 seizures. The seizures varied in intensity. During this time, his anti- seizure medication regimen would adjust based on weight. He was on Keppra from 2012 to Mar2019. He was then switched to Lamictal (lamotrigine). On 03Jun2021, withheld received his first Pfizer-BioNTech COVID-19 vaccine. One week later on 10Jun2021 had a minor seizure at school. Prior to that, withheld had been seizure free since 01Aug2022; almost 2 years without any seizure. 03Jun2021 Dose 1: 10Jun2021 minor seizure, 24Jun2021 Dose 2: 03Mar2022 minor seizure 13Jul2022 Booster dose: 01Aug2022 moderate seizure  Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Acne, Arthralgia, Condition aggravated, Dry mouth, Food intolerance
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Parosmia, Taste disorder, Tinnitus
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Acne, Ageusia, Amnesia, Anosmia, Cellulitis
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Deafness, Dry mouth, Economic problem, Glossodynia, Gynaecomastia
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Immune system disorder, Insomnia, Laboratory test, Male sexual dysfunction, Muscle atrophy
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Nausea, New daily persistent headache, Physical disability, Pneumonia, Rash morbilliform
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Retching, Skin discolouration, Therapeutic response unexpected, Tinnitus, Trigger finger
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Vasculitis
Clinical narrative: I was compelled to receive a COVID vaccine priiior to my knee surgery in May 2021. I received two doses of the Pfizer BioNtech vaccine on 02/24/2021 and 03/18/2021. On 03/20/2021 began to develop immune system issues. It began with the total disappearance of my seasonal allergies that I have had for over 50 years. I received allergy shots for approximately 10 years from age 7 through age 16. On 03/21/2021 I developed severe Xerostomia and Glossodynia. Ove the next 16 months I developed numerous disorders including...tinnitus and hearing loss..acne..morbilliform rash..trigger finger..sleeplessness (the first incident lasted 91 hours and then 28 hours, after sleeping for 2 hours and I've had dozens of recurrances)..loss of sense of taste..loss of sense of smell..headaches (I never had a headache until October 2021, then I developed blinding headaches, everyday from the beginning of October 2021 to the middle of January 2022)..severe nausea every morning (with dry heaves until my eyes are black and blue, several times week)..pneumonia (3 times in 6 weeks)..cellulitis..vasculitis..memory loss (my short term memory is nonexistent)..loss of sexual function..gynecomastia..severe muscle loss..loss of income..physical disability. As a result of my layers of disorders, I have been recruited to participate in the FDA-authorized vaccine injury study. I am barely able to make enough money to support myself.
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 01/10/22 presents to EC ED for "potential seizure" "fever". PMHx of " ADD, Anxiety, Depression"
Age: 12.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive, Seizure like phenomena
Clinical narrative: 01/10/22 presents to EC ED for "potential seizure" "fever". PMHx of " ADD, Anxiety, Depression"
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anaemia, Anticoagulant therapy, Asthenia, COVID-19, Cardiac arrest
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Coagulopathy, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Decubitus ulcer, Disseminated intravascular coagulation
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Diverticulum, Duodenal ulcer, Endotracheal intubation, Extravasation, Haematocrit decreased
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haemoglobin decreased, Hypotension, Mobility decreased, Occult blood positive, Oesophagogastroduodenoscopy
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Pulmonary embolism, Respiratory disorder, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thrombocytopenia, Thrombosis, Tissue injury
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Acidosis, Acute kidney injury, Anaemia, Asthenia
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac arrest, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Death
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Decubitus ulcer, Disseminated intravascular coagulation, Diverticulitis, Endotracheal intubation, Extravasation
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Haematocrit decreased, Haemoglobin decreased, Hypotension, Intensive care
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Occult blood positive, Pneumonia, Pulmonary embolism, SARS-CoV-2 test positive, Transfusion
Clinical narrative: 2/15/22 pt to ED with generalized weakness, abdominal pain; new decubitus ulcers; grossly heme positive stool; positive COVID test; hypotensive; given 1 unit of blood; CT of chest, abdomen, pelvis showed multifocal pneumonia, main pulmonary artery pulmonary embolus, severe diverticulitis; vasopressors; ABX; transferred to ICU; pt had a severe drop in hemoglobin and hematocrit; CT abdomen showed acute extravasation from distal duodenum; pt intubated and experienced cardiac arrest during intubation; ROSC achieved after ACS measures; vasopressor support and blood products given; worsening condition; acute renal failure; in DIC; continued to worsen; pt made an intubate only with aggressive measures; continued to be acidotic and anemic; pt passed away in the hospital
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acidosis, Angiogram abnormal, COVID-19 pneumonia, Chest wall mass, Chronic obstructive pulmonary disease
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Clostridium difficile infection, Clostridium test positive, Condition aggravated, Critical illness, Diarrhoea
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disseminated intravascular coagulation, Dyspnoea, Echocardiogram normal, Endotracheal intubation, Fibrin D dimer increased
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Haematoma, Haemofiltration, Hypophagia, Hypotension
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test abnormal, Lethargy, Malaise, Mydriasis, Nausea
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Productive cough, Renal impairment, Respiratory distress, Swelling, Transfusion
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan abnormal, Vomiting
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Asthenia, COVID-19 pneumonia, Cardio-respiratory arrest, Cerebrovascular accident
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Chronic obstructive pulmonary disease, Death, Diarrhoea, Dyspnoea
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea exertional, Endotracheal intubation, Fibrin D dimer increased, Hypophagia, Lung infiltration
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung opacity, Nausea, Productive cough, Pulse absent, Respiratory distress
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling, Vomiting
Clinical narrative: Patient presented to Medical Center on 03/18/2022 with SOB.  She also c/o nausea with vomiting, decreased PO intake, diarrhea, progressively worsening SOB with even minimal exertion and generalized weakness, cough productive pf phlegm.  In ED CXR showed vague nodular opacities possible representing infiltrate's.  Patient was admitted to hospital with COVID PNA and COPD exacerbation.  Patient was treated with IV dexamethasone, and Lovenox d/t elevated D dimer.  She began requiring oxygen, and received Remdesivir.  She was also treated with Doxy and Azithromycin.  Swelling noted on the chest wall.  On 3/23/2022 Code Stroke was called, and developed severe respiratory distress and code intubation called.  Post intubation code blue was called d/t patient being pulseless.  ROSC was obtained.  Patient was placed on multiple pressor.  Comfort care was initiated and patient expired on 03/24/2022.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Amnesia, Dysphagia, Electroencephalogram, Fatigue, Gait disturbance
Clinical narrative: stroke like symptoms; Unable to speak; Unable to move easily; This case was reported by a pharmacist via sales rep and described the occurrence of stroke in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th June 2022 16:00, the patient received the 2nd dose of Shingles vaccine. In June 2022, less than a day after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant), aphasia and mobility decreased. On an unknown date, the outcome of the stroke, aphasia and mobility decreased were unknown.   The reporter considered the stroke, aphasia and mobility decreased to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The patient had applied for the claim after Shingles vaccination. On 27th June 2022, the next morning after vaccination, the patient was unable to speak, move easily and she got to her neighbor's house and was transported to the hospital. The patient alleged stroke like symptoms from the vaccine. The consent to follow-up was granted. Additional Supportive Information: Onset date was captured partially, to capture a correct time to onset as per narrative.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Immunisation reaction, Laboratory test, Loss of control of legs, Magnetic resonance imaging normal, Malaise
Clinical narrative: stroke like symptoms; Unable to speak; Unable to move easily; This case was reported by a pharmacist via sales rep and described the occurrence of stroke in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th June 2022 16:00, the patient received the 2nd dose of Shingles vaccine. In June 2022, less than a day after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant), aphasia and mobility decreased. On an unknown date, the outcome of the stroke, aphasia and mobility decreased were unknown.   The reporter considered the stroke, aphasia and mobility decreased to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The patient had applied for the claim after Shingles vaccination. On 27th June 2022, the next morning after vaccination, the patient was unable to speak, move easily and she got to her neighbor's house and was transported to the hospital. The patient alleged stroke like symptoms from the vaccine. The consent to follow-up was granted. Additional Supportive Information: Onset date was captured partially, to capture a correct time to onset as per narrative.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Mobility decreased, Nausea, Neurological symptom, Pain in extremity, Panic attack
Clinical narrative: stroke like symptoms; Unable to speak; Unable to move easily; This case was reported by a pharmacist via sales rep and described the occurrence of stroke in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th June 2022 16:00, the patient received the 2nd dose of Shingles vaccine. In June 2022, less than a day after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant), aphasia and mobility decreased. On an unknown date, the outcome of the stroke, aphasia and mobility decreased were unknown.   The reporter considered the stroke, aphasia and mobility decreased to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The patient had applied for the claim after Shingles vaccination. On 27th June 2022, the next morning after vaccination, the patient was unable to speak, move easily and she got to her neighbor's house and was transported to the hospital. The patient alleged stroke like symptoms from the vaccine. The consent to follow-up was granted. Additional Supportive Information: Onset date was captured partially, to capture a correct time to onset as per narrative.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Seizure like phenomena, Speech disorder, Vomiting
Clinical narrative: stroke like symptoms; Unable to speak; Unable to move easily; This case was reported by a pharmacist via sales rep and described the occurrence of stroke in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th June 2022 16:00, the patient received the 2nd dose of Shingles vaccine. In June 2022, less than a day after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant), aphasia and mobility decreased. On an unknown date, the outcome of the stroke, aphasia and mobility decreased were unknown.   The reporter considered the stroke, aphasia and mobility decreased to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The patient had applied for the claim after Shingles vaccination. On 27th June 2022, the next morning after vaccination, the patient was unable to speak, move easily and she got to her neighbor's house and was transported to the hospital. The patient alleged stroke like symptoms from the vaccine. The consent to follow-up was granted. Additional Supportive Information: Onset date was captured partially, to capture a correct time to onset as per narrative.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Aphasia, Cerebrovascular accident, Mobility decreased, Neurological symptom, Speech disorder
Clinical narrative: stroke like symptoms; Unable to speak; Unable to move easily; This case was reported by a pharmacist via sales rep and described the occurrence of stroke in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th June 2022 16:00, the patient received the 2nd dose of Shingles vaccine. In June 2022, less than a day after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant), aphasia and mobility decreased. On an unknown date, the outcome of the stroke, aphasia and mobility decreased were unknown.   The reporter considered the stroke, aphasia and mobility decreased to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The patient had applied for the claim after Shingles vaccination. On 27th June 2022, the next morning after vaccination, the patient was unable to speak, move easily and she got to her neighbor's house and was transported to the hospital. The patient alleged stroke like symptoms from the vaccine. The consent to follow-up was granted. Additional Supportive Information: Onset date was captured partially, to capture a correct time to onset as per narrative.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal, Head discomfort, Hypoaesthesia, Immediate post-injection reaction
Clinical narrative: Patient chef complaint about Novovax is that for left arm is numb as well as her left face. I told her it's one of the side effects and use treatment such as cold compress and drink plenty of water and also moved the left arm more to lessen side effect. If it persist more than 1 week, advised her to check with her PCP.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: Patient chef complaint about Novovax is that for left arm is numb as well as her left face. I told her it's one of the side effects and use treatment such as cold compress and drink plenty of water and also moved the left arm more to lessen side effect. If it persist more than 1 week, advised her to check with her PCP.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Patient chef complaint about Novovax is that for left arm is numb as well as her left face. I told her it's one of the side effects and use treatment such as cold compress and drink plenty of water and also moved the left arm more to lessen side effect. If it persist more than 1 week, advised her to check with her PCP.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Pemphigoid, Pruritus
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Aug2021 as dose 1, single (Batch/Lot number: unknown) and in Aug2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Bullous Pemphigoid" (unspecified if ongoing), notes: This is the 8th year have auto immune disease. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1), administration date: Aug2021, for COVID-19 immunization, reaction(s): "Bullous Pemphigoid". The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 04Jul2022, outcome "unknown" and all described as "got COVID/very sick for 10days. Very bad sore throat extreme fatigue and no fever". Patient had been ok until got COVID on 04Jul2022. Patient thought omicron. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.